Clinical Trial Update: Phaco vs. Phaco-ELT vs. Phaco-Trabectome 12m

View source ↗

Summary

A 12-month update comparing Phaco, Phaco-ELT, and Phaco-Trabectome for patients with glaucoma and cataract, sponsored by the University of Zurich.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Glaucoma

Snippet

Sponsor: University of Zurich | Conditions: Glaucoma, Cataract | Status: COMPLETED